An active-comparator new-user cohort design is less susceptible to healthy user bias and confounding by indication, because an active treatment with similar indication rather than non-users is the comparator [31, 32]
The Current Challenges in Regenerative Medicine It Addresses Modern medicine faces significant challenges in managing conditions characterized by chronic, low-grade inflammation and a diminished capacity for tissue repairhallmarks of the aging process
Food and Drug Administration (FDA) issued a new warning about the potential for Ozempic to cause intestinal blockages
Taken together, it has been proposed that muscle loss during GLP-1 RAs-based therapy is largely adaptive and proportional to overall weight reduction, and that improvements in muscle quality and insulin sensitivity may help offset potential functional decline [97]
Subjects with diabetes or impaired glucose tolerance show significantly reduced levels of meal-stimulated circulating GIP and the levels are negatively correlated with the severity of IR in the patients (65, 66)
People experiencing constipation on semaglutide or constipation on tirzepatide may find that butyrate-producing bacteria like Clostridium butyricum support bowel regularity through improved colonocyte function and motility